Event Details

NewYorkBIO has partnered with NYSE to bring together New York's financial community and emerging companies developing novel therapeutics in areas which could revolutionize patient care.

Dec 14, 2022

12:00 PM - 6:00 PM (GMT-5)

Add to Calendar

The New York Stock Exchange
11 Wall Street
New York, NY

Show on map

Agenda

  • 12:00 PM - 1:00 PMNetworking Lunch
    1:00 PM - 1:05 PMWelcome Remarks
    Opening remarks from NewYorkBIO CEO, Jennifer Hawks Bland.
    1:05 PM - 2:05 PMCompany Presentations
    Featuring presentations from Genomic Expressions and Synchron

    Thomas Oxley

    Founder and CEO of Synchron

    Gitte Pederson

    Co-Founder and CEO of Genomic Expression

    Ryan Saadi

    CEO of Tevogen

    Sarah Ashfaq

    Partner at Goodwin

    2:05 PM - 2:35 PMNetworking Break
    2:35 PM - 3:35 PMCompany Presentations
    Featuring presentations from Artios and Ochre Bio

    Janelle Anderson

    Chief Business Officer at F2G

    Tania Dimitrova

    CBO at Artios Inc.

    David Sans

    Chief Corporate Development at Calidi Therapeutics

    Alan Tamarelli

    Partner at Cooley LLP

    3:35 PM - 3:40 PMBreak
    3:40 PM - 4:15 PMClosing Bell
    4:15 PM - 5:15 PMCompany Presentations
    Featuring three presentations from Atsena, F2G, and Versaris

    Mark Pruzanski

    Chairman and CEO of Versanis Bio

    Patrick Ritschel

    CEO of Atsena Therapeutics

    Jack O'Meara

    Founder and CEO of Ochre Bio

    5:15 PM - 5:55 PMPanel Discussion
    Sponsored by Woodruff Sawyer

    Jack Bannister

    Senior Managing Director of Svb Securities

    Sean Coady

    Senior Vice President at Woodruff Sawyer

    Christina Jenkins

    Venture Partner at PVP

    Ario Arabi

    Global BD&L Partnering – Executive Director of Novartis

    5:55 PM - 6:00 PMClosing Remarks

Community

Connect with 139 people attending this event

Tickets Register

Virtual Attendee

Select this option if you would like to livestream the event.

Free
Menu